Fat-soluble vitamin compounds for targeting drug delivery and enhancing siRNA activity

Here described are compounds of formula I: wherein R1 and R2 is independently selected from a group consisting of C10 to C18 alkyl, C12 to C18 alkenyl, and oleoyl group; wherein R3 and R4 are independently selected from a group consisting of H, C1 to C6 alkyl, and C1 to C6 alkanol; wherein X is sele...

Full description

Saved in:
Bibliographic Details
Main Authors HOU, ZHENG, KARMALI, PRIYA, PAYNE, JOSEPH E, AKOPIAN, VIOLETTA, NAGARAJAN, SRIDHAR C, KNOPOV, VICTOR, AHMADIAN, MOHAMMAD, PERELMAN, LOREN A, WITTE, RICHARD P, GAUDETTE, JOHN A, TANAKA, YASUNOBU, NIITSU, YOSHIRO
Format Patent
LanguageChinese
English
Published 01.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Here described are compounds of formula I: wherein R1 and R2 is independently selected from a group consisting of C10 to C18 alkyl, C12 to C18 alkenyl, and oleoyl group; wherein R3 and R4 are independently selected from a group consisting of H, C1 to C6 alkyl, and C1 to C6 alkanol; wherein X is selected from a group consisting of -CH2-, -S-, and -O-; wherein Y is selected from -(CH2)n, -S(CH2)n, -O(CH2)n-, thiophene, -SO2(CH2)n-, and ester, wherein n = 1-4; and wherein Z is a counterion; and compounds consisting of the structure (targeting molecule)n-linker-(targeting molecule)n, wherein the targeting molecule is a retinoid or a fat soluble vitamin having a specific receptor on the target cell; wherein n=0, 1, 2 or 3; and wherein the linker comprises a polyethylene glycol (PEG) or PEG-like molecule, as well as compositions and pharmaceutical formulations including one or both of these compounds which are useful for the delivery of therapeutic agents; and methods of using these compositions and pharmaceutical
Bibliography:Application Number: TW20121120844